Succinate salt of O-desmethyl-venlafaxine
View Patent ↗A novel salt of O-desmethyl venlafaxine is provided, O-desmethylvenlafaxine succinate. Pharmaceutical compositions, dosage forms and methods of use are also provided.
1. An oral dosage form comprising O-desmethyl venlafaxine succinate, wherein the oral dosage form is a tablet.
2. An oral dosage form comprising O-desmethyl venlafaxine succinate, wherein the oral dosage form is a capsule.
3. The oral dosage form of claim 1 or 2 , wherein the oral dosage form comprises from about 30% to about 50% by weight of O-desmethyl venlafaxine succinate.
4. The oral dosage form of claim 1 or 2 , wherein the oral dosage form comprises from about 32% to about 44% by weight of O-desmethyl venlafaxine succinate.
5. The oral dosage form of claim 1 or 2 , wherein the oral dosage form comprises about 50% by weight of O-desmethyl venlafaxine succinate.
6. The oral dosage form of claim 1 or 2 , wherein the oral dosage form comprises about 44% by weight of O-desmethyl venlafaxine succinate.
7. The dosage form of claim 1 or 2 , wherein each dosage form contains from about 15 mg to about 350 mg of O-desmethyl venlafaxine succinate.
8. The dosage form of claim 1 or 2 , wherein each dosage form contains from about 10 mg to about 1000 mg of O-desmethyl venlafaxine succinate.
9. The dosage form of claim 1 or 2 , wherein each dosage form contains 200 mg of O-desmethyl venlafaxine succinate.